MedPath

itrous oxide and cerebral vasodilatation: a dose-response study in healthy volunteers

Phase 1
Conditions
The study will be conducted in healthy volunteers. I will evaluate the effects of inhaled concentrations of nitrous oxide, ranging from 0% to 50%, on cerebral blood flow and cerebral vascular tone in a dose related manner.
Registration Number
EUCTR2007-007094-23-GB
Lead Sponsor
niversity of Nottingham
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

•Healthy volunteers aged between 18 and 50 years

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

•History or evidence of a systemic illness or vascular disease
•On prescription medication which may affect cardiovascular system
•Any evidence of neurological disorder
•Previous neurological surgery
•Smokers
•Pregnant or lactating females

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath